Celleron Therapeutics Venture Capital
Oxford, GB · 1 known investors
IngenOx Therapeutics is a clinical-stage biopharmaceutical company developing precision drugs and cancer vaccines for patients with advanced, treatment-resistant cancers that evade the immune system. Based in Oxford, UK, it uses an in-house discovery platform for both small-molecule drug development and vaccine development targeting immunologically cold tumours.
Investors · 1
Frequently asked questions
- What does Celleron Therapeutics Venture Capital do?
- IngenOx Therapeutics is a clinical-stage biopharmaceutical company developing precision drugs and cancer vaccines for patients with advanced, treatment-resistant cancers that evade the immune system. Based in Oxford, UK, it uses an in-house discovery platform for both small-molecule drug development and vaccine development targeting immunologically cold tumours.
- Who are Celleron Therapeutics Venture Capital's investors?
- Celleron Therapeutics Venture Capital's investors include IMM Investment Japan.
- Where is Celleron Therapeutics Venture Capital headquartered?
- Celleron Therapeutics Venture Capital is headquartered in Oxford, GB.